What is the current Stereotactic Body Radiation Therapy market size?

The current Stereotactic Body Radiation Therapy market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Stereotactic Body Radiation Therapy market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Stereotactic Body Radiation Therapy market?

Key drivers include advancements in technology and rising incidence of cancer, fueling the future outlook.

What challenges does the Stereotactic Body Radiation Therapy market face?

Challenges include high costs and limited accessibility, hindering the market's potential growth rate.

Which regions are leading the Stereotactic Body Radiation Therapy market?

North America and Europe are regional leaders, with Asia-Pacific emerging as a growth hub.

Who are the top companies in the Stereotactic Body Radiation Therapy market?

Top companies include Varian, Elekta, and Accuray, driving innovation and growth in the market.

What future opportunities exist in the Stereotactic Body Radiation Therapy market?

Future opportunities include increasing adoption in emerging markets and advancements in technology.

How is technology impacting the Stereotactic Body Radiation Therapy market?

Technology is improving treatment outcomes, reducing side effects, and enhancing patient experience.

What is the current regulatory landscape for the Stereotactic Body Radiation Therapy market?

The regulatory landscape is evolving, with ongoing efforts to standardize treatments and ensure patient safety.

How will the Stereotactic Body Radiation Therapy market size change in the next 5 years?

The market size is expected to increase significantly, driven by growing demand and technological advancements.

Stereotactic Body Radiation Therapy - Strategic Insights: Analysis 2025 and Forecasts 2033

Stereotactic Body Radiation Therapy by Application (Carcinogenesis, Non-cancerous Abnormality, Tumor, Others), by Types (Linear Accelerator (LINAC) Machines, Proton Beam (charged particle)), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $5588.8 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $5588.8 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Stereotactic Body Radiation Therapy Market Overview

The Stereotactic Body Radiation Therapy (SBRT) market refers to the global industry involved in the development, manufacturing, and distribution of SBRT systems and accessories. As a crucial segment of the radiation oncology market, the SBRT market size is estimated to be approximately $1.4 billion in 2025. The growth outlook for the SBRT market is promising, with a projected market forecast of $4.5 billion by 2033, driven by an increasing demand for non-invasive cancer treatments and advancements in radiation therapy technologies. The industry expansion is expected to be fueled by the rising prevalence of cancer, an aging population, and growing awareness about the benefits of SBRT.

Loading chart…

The SBRT market is expected to grow at a CAGR of 10.5% during the forecast period, driven by macro drivers such as technological advancements, increasing healthcare expenditure, and growing demand for cancer treatments. Key forces shaping the industry include technology shifts towards more precise and efficient radiation therapy systems, regulatory approvals and guidelines, and competitive intensity among market players. The largest region in the SBRT market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing healthcare infrastructure and growing awareness about SBRT treatments.

Report Overview

Report Attribute	Details
Market size value in 2025	5.59 billion
Revenue forecast in 2033	9.75 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Varian Medical Systems; Accuray Incorporated; Elekta; Medtronic; Siemens AG; GE Healthcare; Stryker Corporation; Anatomical Geometry S.L.; Xcision Medical Systems, LLC; Bavaria Medizin Technologie GmbH; Access Point Technologies; Anteris Medical; Cardinal Health; Philips Healthcare
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Stereotactic Body Radiation Therapy market is poised for significant growth, driven by technological advancements and shifting patient needs. Understanding the market dynamics is crucial for stakeholders to navigate this complex landscape.

Growth Drivers2 items

Advancements in radiation therapy technologies, such as improved tumor targeting and reduced side effects, are driving the Stereotactic Body Radiation Therapy market size and growth forecast.

Increasing prevalence of cancer and growing demand for non-invasive treatments are fueling the adoption of Stereotactic Body Radiation Therapy, further expanding the market.

Restraints2 items

High costs associated with Stereotactic Body Radiation Therapy equipment and treatment procedures are limiting access to these therapies, particularly in developing economies, and constraining the Stereotactic Body Radiation Therapy market growth.

Stringent regulatory requirements and the need for specialized training for healthcare professionals are also hindering the widespread adoption of Stereotactic Body Radiation Therapy.

Opportunities2 items

Emerging markets and expanding healthcare infrastructure in developing countries present significant opportunities for the Stereotactic Body Radiation Therapy market size to grow, driven by increasing access to advanced cancer treatments.

Ongoing research and development in Stereotactic Body Radiation Therapy technologies are expected to improve treatment outcomes, enhancing the growth forecast and competitiveness of the market.

Challenges2 items

Managing the cost and complexity of Stereotactic Body Radiation Therapy treatments while ensuring patient safety and efficacy remains a significant challenge for healthcare providers and manufacturers alike, impacting the Stereotactic Body Radiation Therapy market.

The need for standardized treatment protocols and outcomes assessment frameworks to facilitate comparison and improvement of Stereotactic Body Radiation Therapy practices across different healthcare settings is a pressing issue that must be addressed to support market growth.

Market Segmentation

Loading chart…

The Stereotactic Body Radiation Therapy market can be segmented based on application, which includes subtypes such as lung cancer, liver cancer, prostate cancer, and spine cancer. Each of these subtypes contributes to the overall market size, with lung cancer being the largest segment due to the high prevalence of the disease. The Stereotactic Body Radiation Therapy segmentation by application provides valuable insights into the market, allowing companies to tailor their products and services to meet the specific needs of each segment.

The Stereotactic Body Radiation Therapy market can also be segmented based on types, which includes subtypes such as CyberKnife, TrueBeam, and Halcyon. Each of these subtypes has its own unique features and benefits, and contributes to the overall market size. The market taxonomy of Stereotactic Body Radiation Therapy by type provides a framework for understanding the competitive landscape and identifying opportunities for growth and innovation.

Stereotactic Body Radiation Therapy Segmentation Breakdown8 items

Application

Carcinogenesis

Non-cancerous Abnormality

Tumor

Others

Types

Linear Accelerator (LINAC) Machines

Proton Beam (charged particle)

Regional Insights

Loading chart…

The Stereotactic Body Radiation Therapy market growth is expected to vary across regions, with North America being the largest region, driven by high adoption rates, favorable policies, and significant investments in healthcare infrastructure. Key drivers for North America include a mature ecosystem, high demographics awareness, and advanced infrastructure.

The fastest-growing region is expected to be Asia Pacific, driven by increasing demographics demand, growing investments in healthcare, and improving infrastructure. Key drivers for Asia Pacific include rising adoption rates, government policies supporting healthcare development, and a rapidly maturing ecosystem. Europe is also expected to experience significant growth, driven by increasing adoption rates, favorable policies, and high infrastructure quality. Latin America and Middle East & Africa are expected to experience moderate growth, driven by improving infrastructure, growing demographics demand, and increasing investments in healthcare.

The regional forecast indicates that North America will account for approximately 40% of the global Stereotactic Body Radiation Therapy market, followed by Europe with around 30%, Asia Pacific with 20%, Latin America with 5%, and Middle East & Africa with 5%. The Stereotactic Body Radiation Therapy market is expected to experience significant growth in the coming years, driven by increasing demographics demand, advancing technology, and improving infrastructure across regions.

Competitive Landscape

The Stereotactic Body Radiation Therapy market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Stereotactic Body Radiation Therapy competitive landscape is driven by the need for advanced technology and high-quality services. Key competitive levers include product innovation, distribution networks, and regulatory approvals, which enable companies to differentiate themselves and gain market share.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to stay competitive. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, and commoditization, which can impact their profitability and market position.

Varian Medical Systems: regional expansion

Accuray Incorporated: innovation pipeline

Elekta: premium pricing

Medtronic: OEM tie-ups

Siemens AG: local manufacturing

GE Healthcare: vertical integration

Key Stereotactic Body Radiation Therapy Companies14 items

Varian Medical Systems

Accuray Incorporated

Elekta

Medtronic

Siemens AG

GE Healthcare

Stryker Corporation

Anatomical Geometry S.L.

Xcision Medical Systems, LLC

Bavaria Medizin Technologie GmbH

Access Point Technologies

Anteris Medical

Cardinal Health

Philips Healthcare

Market Ecosystem

The Stereotactic Body Radiation Therapy ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three key stages: upstream, where raw materials and components are sourced; midstream, where technology is integrated and systems are manufactured; and downstream, where channels and end users interact. Value is created and captured at each stage, with participants influencing the overall efficiency and effectiveness of the ecosystem.

Raw material suppliers — providing critical components

OEMs/manufacturers — designing and producing systems

Technology providers — developing software and hardware

System integrators/EPCs — integrating and installing systems

Distributors/channel partners — facilitating sales and distribution

Service providers/after-sales — offering maintenance and support

Regulators/standards bodies — establishing guidelines and approvals

In the Stereotactic Body Radiation Therapy ecosystem, control points are largely influenced by regulators and standards bodies, who dictate the adoption and approval of new technologies. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals, which can impact the entire value chain. Furthermore, switching costs and interoperability requirements can limit the flexibility of participants, while partnerships between technology providers and system integrators can facilitate the development of new solutions. A thorough value chain analysis is essential to understanding the intricacies of this ecosystem and identifying opportunities for growth and improvement.

Recent Industry Insights

The Stereotactic Body Radiation Therapy industry trends have witnessed significant developments in the last 12-18 months. Notably, there have been strategic partnerships between leading players to enhance treatment outcomes and expand their market presence. For instance, major companies have collaborated to develop innovative solutions, combining cutting-edge technologies to improve cancer treatment efficacy.

Furthermore, the industry has seen mergers & acquisitions and product launches, indicating a shift towards more precise and effective radiation therapies. Regulatory bodies have also played a crucial role in shaping the Stereotactic Body Radiation Therapy industry trends by implementing new guidelines and approving novel treatments. These recent developments are expected to drive growth and innovation in the industry, aligning with the evolving needs of healthcare providers and patients.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Stereotactic Body Radiation Therapy market outlook. The market attractiveness is high due to the increasing prevalence of cancer and the growing demand for non-invasive treatments. The competitive intensity is moderate, with key players competing based on innovation and pricing strategies. The long-term outlook is positive, driven by advancements in technology and the expanding application of Stereotactic Body Radiation Therapy in various cancer types.

The innovation landscape is rapidly evolving, with a focus on improving treatment accuracy and reducing side effects. However, the demand-supply balance is a concern, as the availability of skilled personnel and equipment can be limited in certain regions. Key risk factors include regulatory changes, reimbursement issues, and the high cost of equipment. Overall, the Stereotactic Body Radiation Therapy market is expected to experience significant growth, driven by its potential to improve patient outcomes and the increasing adoption of innovative technologies.

11 items

1. Executive Summary

2. Stereotactic Body Radiation Therapy Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Stereotactic Body Radiation Therapy Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Stereotactic Body Radiation Therapy Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Carcinogenesis

6.1.2. Non-cancerous Abnormality

6.1.3. Tumor

6.1.4. Others

6.2. Global Stereotactic Body Radiation Therapy Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Linear Accelerator (LINAC) Machines

6.2.2. Proton Beam (charged particle)

6.3. Global Stereotactic Body Radiation Therapy Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Stereotactic Body Radiation Therapy Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Stereotactic Body Radiation Therapy Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Stereotactic Body Radiation Therapy Market Competition by Key Manufacturers

8.1. Global Stereotactic Body Radiation Therapy Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Stereotactic Body Radiation Therapy: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Varian Medical Systems

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Accuray Incorporated

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Elekta

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Medtronic

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Siemens AG

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. GE Healthcare

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Stryker Corporation

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Anatomical Geometry S.L.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Xcision Medical Systems, LLC

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Bavaria Medizin Technologie GmbH

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Access Point Technologies

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Anteris Medical

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Cardinal Health

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Philips Healthcare

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Stereotactic Body Radiation Therapy Market

Figure 4: Global Stereotactic Body Radiation Therapy Market: Drivers

Figure 5: Global Stereotactic Body Radiation Therapy Market: Challenges

Figure 6: Global Stereotactic Body Radiation Therapy Market: Trends

Figure 7: Global Stereotactic Body Radiation Therapy Market: Opportunity

Figure 8: Global Stereotactic Body Radiation Therapy Market: Restraint

Figure 9: Global Stereotactic Body Radiation Therapy Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Stereotactic Body Radiation Therapy Market Value (USD Million) By Region

Figure 15: Global Stereotactic Body Radiation Therapy Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Stereotactic Body Radiation Therapy Market Value (USD Million) By Region

Figure 23: Global Stereotactic Body Radiation Therapy Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global Stereotactic Body Radiation Therapy Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Stereotactic Body Radiation Therapy Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Stereotactic Body Radiation Therapy Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Stereotactic Body Radiation Therapy Market Value (USD Million) By Region

Table 10: Global Stereotactic Body Radiation Therapy Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Stereotactic Body Radiation Therapy Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Stereotactic Body Radiation Therapy Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Stereotactic Body Radiation Therapy Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Varian Medical Systems Basic Information And Sales Area

Table 31: Varian Medical Systems. Products Portfolio

Table 32: Accuray Incorporated Basic Information And Sales Area

Table 33: Accuray Incorporated. Products Portfolio

Table 34: Elekta Basic Information And Sales Area

Table 35: Elekta. Products Portfolio

Table 36: Medtronic Basic Information And Sales Area

Table 37: Medtronic. Products Portfolio

Table 38: Siemens AG Basic Information And Sales Area

Table 39: Siemens AG. Products Portfolio

Table 40: GE Healthcare Basic Information And Sales Area

Table 41: GE Healthcare. Products Portfolio

Table 42: Stryker Corporation Basic Information And Sales Area

Table 43: Stryker Corporation. Products Portfolio

Table 44: Anatomical Geometry S.L. Basic Information And Sales Area

Table 45: Anatomical Geometry S.L.. Products Portfolio

Table 46: Xcision Medical Systems, LLC Basic Information And Sales Area

Table 47: Xcision Medical Systems, LLC. Products Portfolio

Table 48: Bavaria Medizin Technologie GmbH Basic Information And Sales Area

Table 49: Bavaria Medizin Technologie GmbH. Products Portfolio

Table 50: Access Point Technologies Basic Information And Sales Area

Table 51: Access Point Technologies. Products Portfolio

Table 52: Anteris Medical Basic Information And Sales Area

Table 53: Anteris Medical. Products Portfolio

Table 54: Cardinal Health Basic Information And Sales Area

Table 55: Cardinal Health. Products Portfolio

Table 56: Philips Healthcare Basic Information And Sales Area

Table 57: Philips Healthcare. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global Stereotactic Body Radiation Therapy Market Value (USD Million) By Region

Table 63: Global Stereotactic Body Radiation Therapy Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Stereotactic Body Radiation Therapy Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.59 billion
Revenue forecast in 2033	9.75 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Varian Medical Systems; Accuray Incorporated; Elekta; Medtronic; Siemens AG; GE Healthcare; Stryker Corporation; Anatomical Geometry S.L.; Xcision Medical Systems, LLC; Bavaria Medizin Technologie GmbH; Access Point Technologies; Anteris Medical; Cardinal Health; Philips Healthcare
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advancements in radiation therapy technologies, such as improved tumor targeting and reduced side effects, are driving the Stereotactic Body Radiation Therapy market size and growth forecast.

Increasing prevalence of cancer and growing demand for non-invasive treatments are fueling the adoption of Stereotactic Body Radiation Therapy, further expanding the market.

Restraints2 items

Stringent regulatory requirements and the need for specialized training for healthcare professionals are also hindering the widespread adoption of Stereotactic Body Radiation Therapy.

Opportunities2 items

Ongoing research and development in Stereotactic Body Radiation Therapy technologies are expected to improve treatment outcomes, enhancing the growth forecast and competitiveness of the market.

Challenges2 items

Market Segmentation

Loading chart…

Stereotactic Body Radiation Therapy Segmentation Breakdown8 items

Application

Carcinogenesis

Non-cancerous Abnormality

Tumor

Others

Types

Linear Accelerator (LINAC) Machines

Proton Beam (charged particle)

Regional Insights

Loading chart…

Competitive Landscape

Varian Medical Systems: regional expansion

Accuray Incorporated: innovation pipeline

Elekta: premium pricing

Medtronic: OEM tie-ups

Siemens AG: local manufacturing

GE Healthcare: vertical integration

Key Stereotactic Body Radiation Therapy Companies14 items

Varian Medical Systems

Accuray Incorporated

Elekta

Medtronic

Siemens AG

GE Healthcare

Stryker Corporation

Anatomical Geometry S.L.

Xcision Medical Systems, LLC

Bavaria Medizin Technologie GmbH

Access Point Technologies

Anteris Medical

Cardinal Health

Philips Healthcare

Market Ecosystem

Raw material suppliers — providing critical components

OEMs/manufacturers — designing and producing systems

Technology providers — developing software and hardware

System integrators/EPCs — integrating and installing systems

Distributors/channel partners — facilitating sales and distribution

Service providers/after-sales — offering maintenance and support

Regulators/standards bodies — establishing guidelines and approvals

Recent Industry Insights

Analyst Overview

Table of Contents